<DOC>
	<DOCNO>NCT02820584</DOCNO>
	<brief_summary>Mono-center , un-controlled , open label , first human , clinical trial . Approximately 20 patient ( order achieve 12 valuable patient ) . The expected accrual time would range 12 18 month . Follow-up , include clinical , immune radiological monitor end two year initial surgery last patient enrol . The primary objective ass activity immunotherapy term effect immune response . In particular investigate effect treatment effector cell include CD8 T cell , NK cell Natural Killer T ( NKT ) cell . The sample size 12 eligible patient identify ethical practical consideration , rather formal sample size calculation .</brief_summary>
	<brief_title>A Phase I Study Immunotherapy With GSC -Loaded Dendritic Cells Patients With Recurrent Glioblastoma</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<criteria>Age ≥18 ≤70 year ; Histological diagnosis de novo GBM ( i.e . secondary GBM ) ; Gross total resection evaluate MRI perform within 72 hour surgery ; Karnofsky Performance Status ( KPS ) ≥60 time first progression ; Written inform consent . Pregnancy breast feeding ; Participation clinical trial experimental drug simultaneously ; Mandatory treatment corticosteroid salicylates antiinflammatory dose ; Presence subependymal diffusion tumor ; Presence multifocal GBM lesion ; Haematology : leukocyte ( WBC ) &lt; 3x103/μl , absolute lymphocyte count &lt; 0.5x103/μl , Absolute neutrophil count ( ANC ) &lt; 1x103/μl , hemoglobin &lt; 9 g/dL , platelet &lt; 50x103/μl within two day prior leukapheresis ; AST ( SGOT ) /ALT ( SGPT ) ≥3 X institutional Upper Limit Normal ( ULN ) time leukapheresis ; Serum creatinine &gt; 1.5 ULN calculate creatinine clearance &lt; 60 ml/min time surgery ; Documented immune deficiency ; Documented systemic autoimmune disease ; Positivity HBV , HIV , HCV , Treponema Pallidum ; Allergies component DC vaccine ; Other active malignancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>